Back Login for AI Analysis

    NKTR (STOCKS)

    Nektar Therapeutics

    $80.450000
    +2.950000 (+3.81%)
    Prev close: $77.500000
    Company Information
    Exchange
    XNAS
    Sector
    Health Technology
    Industry
    Pharmaceuticals: Major
    CEO
    Howard W. Robin
    Asset Type
    stocks
    Website
    Visit
    Fundamentals
    Market Cap
    $2,308.24M
    Employees
    61
    P/E (TTM)
    -7.58
    P/B (TTM)
    17.58
    Dividend Yield
    Technical Indicators
    SMA 10
    SMA 20
    SMA 50
    EMA 9
    EMA 21
    RSI
    MACD State
    Recent News

    No recent news found for this ticker.

    Financial Statements
    TTM (Dec 2025)
    Revenues $55.23M
    Benefits Costs and Expenses $219.45M
    Cost Of Revenue $0.00
    Costs And Expenses $195.33M
    Nonoperating Income/Loss -$15.39M
    Operating Expenses $195.33M
    Depreciation and Amortization $1.03M
    Research and Development $117.33M
    Other Operating Expenses $76.98M
    Operating Income/Loss -$140.10M
    Income/Loss Before Equity Method Investments -$155.49M
    Income/Loss From Continuing Operations After Tax -$164.08M
    Income/Loss From Continuing Operations Before Tax -$164.21M
    Income/Loss From Equity Method Investments -$8.73M
    Income Tax Expense/Benefit -$138.00K
    Income Tax Expense/Benefit, Current -$202.00K
    Income Tax Expense/Benefit, Deferred $64.00K
    Net Income/Loss -$164.08M
    Net Income/Loss Attributable To Noncontrolling Interest $0.00
    Net Income/Loss Attributable To Parent -$164.08M
    Net Income/Loss Available To Common Stockholders, Basic -$164.08M
    Participating Securities, Distributed And Undistributed Earnings/Loss, Basic $0.00
    Preferred Stock Dividends And Other Adjustments $0.00
    Basic Earnings Per Share -$9.73
    Diluted Earnings Per Share -$9.73
    Basic Average Shares 16,870,930
    Diluted Average Shares 16,870,930
    Assets $280.41M
    Current Assets $266.27M
    Inventory $0.00
    Noncurrent Assets $14.14M
    Fixed Assets $2.06M
    Other Non-current Assets $12.08M
    Liabilities $190.57M
    Current Liabilities $53.54M
    Accounts Payable $10.77M
    Wages $2.94M
    Other Current Liabilities $39.83M
    Noncurrent Liabilities $137.04M
    Equity $89.83M
    Equity Attributable To Noncontrolling Interest $0.00
    Equity Attributable To Parent $89.83M
    Liabilities And Equity $280.41M
    Net Cash Flow From Operating Activities -$208.51M
    Net Cash Flow From Operating Activities, Continuing -$208.51M
    Net Cash Flow From Investing Activities -$1.20M
    Net Cash Flow From Investing Activities, Continuing -$1.20M
    Net Cash Flow From Financing Activities $180.57M
    Net Cash Flow From Financing Activities, Continuing $180.57M
    Exchange Gains/Losses $6.00K
    Net Cash Flow -$29.14M
    Net Cash Flow, Continuing -$29.14M
    Comprehensive Income/Loss -$164.12M
    Comprehensive Income/Loss Attributable To Noncontrolling Interest $0.00
    Comprehensive Income/Loss Attributable To Parent -$164.12M
    Other Comprehensive Income/Loss -$44.00K